HCW-9218

N/A

Report date: 2024/06/28 10:19:35

Base Information

Drug NameHCW-9218
Drug Alias NameHCW-9218
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTransforming growth factor beta receptor 2 modulatorsInterleukin-15 stimulants
TargetsTransforming growth factor beta receptor 2Interleukin-15
Therapy Area/IndicationsSolid tumoursPulmonary FibrosisOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHCW Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio IncMasonic Cancer Center, University Of MinnesotaHCW Biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursPulmonary FibrosisPancreatic Neoplasms
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A